AF
NAGE icon

Allworth Financial’s Niagen Bioscience NAGE Stock Holding History

Allworth Financial’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.17K Sell
365
-1,631
-82% -$6.62K ﹤0.01% 4675
2026
Q1 		$8.8K Buy
1,996
+1,882
+1,651% +$10.2K ﹤0.01% 3597
2025
Q4 		$726 Sell
114
-690
-86% -$4.8K ﹤0.01% 4450
2025
Q3 		$7.5K Buy
804
+548
+214% +$5.53K ﹤0.01% 3310
2025
Q2 		$3.69K Buy
+256
New +$2.53K ﹤0.01% 3432

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Allworth Financial's NAGE Position: Q2 2026 in Review

Allworth Financial reduced its Niagen Bioscience (NAGE) stake by 82% in Q2 2026, selling an estimated $6.62K and leaving 365 shares worth $1.17K. The position accounts for ﹤0.01% of the portfolio, ranked #4675.

Allworth Financial first reported a position in NAGE in Q2 2025 and has held it in 5 quarters since. The position peaked at $8.8K in Q1 2026. 139 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

  • Allworth Financial held 365 shares of Niagen Bioscience worth $1.17K as of Q2 2026.
  • Allworth Financial sold 1,631 Niagen Bioscience shares in Q2 2026, an estimated $6.62K.
  • Niagen Bioscience made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #4675 holding.
  • Allworth Financial first reported a position in Niagen Bioscience in Q2 2025 and has held it in 5 quarters since.
  • Allworth Financial's Niagen Bioscience position peaked at $8.8K in Q1 2026.
  • 139 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.